← Back to headlines
Veradermics Stock Rises on Positive Hair Loss Drug Trial Data
Veradermics saw its stock increase following positive mid-stage trial data for its lead drug, which is being developed to treat female pattern hair loss.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
